ASX announcements

  • Application for quotation of securities - ALQ

    20 DEC 2024

    DOWNLOAD 
  • ALS PFAS Presentation

    10 DEC 2024

    DOWNLOAD 
  • DRP Price for Interim Dividend HY25

    09 DEC 2024

    DOWNLOAD 
  • Change in substantial holding

    29 NOV 2024

    DOWNLOAD 
  • Notification of cessation of securities - ALQ

    25 NOV 2024

    DOWNLOAD 

 

VIEW ALL

Important dates

  • H1 FY25 result release

    19 NOV 2024

  • FY25 result release

    27 MAY 2025 

  • Annual general meeting

    30 JUL 2025

  • H1 FY26 result release

    18 NOV 2025 

VIEW ALL

ALS Limited

15.250
-0.781 %
ASX:ALQ
Open
15.250
High
15.430
Low
15.180
InvestorServe Log In

Important documents

Esta é uma imagem de um microfone

Financial reports

Access our half-year and full-year financial reports.

LEARN MORE
Relatórios anuais

Investor presentations

Browse through our investor presentations.

LEARN MORE
Esta é uma imagem de um microfone numa sala de reuniões

ASX announcements

View important information about our company through regular ASX announcements.

LEARN MORE

General information

Relevant information for shareholders regarding ALS.

VIEW MORE

Meet the directors of ALS limited

Nigel Garrard

Bachelor of Economics (Adelaide), CA (Chartered Accountant)

Chairman and Independent Non-Executive Director

Nigel Garrard has over 20 years’ experience as an ASX-listed CEO. As CEO of Orora Ltd., he led the demerger of Orora from Amcor and listing of Orora on ASX. He was President of the Amcor Australasia and Packaging Distribution business group, Managing Director of Coca-Cola Amatil’s Food and Services Division, and Managing Director of SPC Ardmona. Nigel is currently a non-executive director of Ansell Limited and CSR Ltd., and Chairman of Flinders Port Holdings Pty. Ltd. and the McMahon Services advisory board.

Malcolm Deane

Master of Laws, Juris Doctor

Chief Executive Officer and Managing Director

Newly appointed as CEO and Managing Director for ALS Limited, Malcolm Deane has served the company in various executive positions for the past 10 years in such roles as GM for Life Sciences Latin America, Food & Pharma Americas, and most recently as the Chief Strategy Officer, leading corporate strategy, business development and acquisitions. Malcolm has a Master of Laws from the University of Virginia School of Law and Juris Doctor from Universidad Austral – Buenos Aires, Argentina.  

John Mulcahy

PhD, B E (Civil Eng) (Hons), FIE Aust

Independent Non-Executive Director

John Mulcahy was appointed a Non-Executive Director of the Company in 2012. He is Chairman of Mirvac Group Limited (appointed November 2009 and Chair September 2013) and Orix Australia Corporation Limited, an unlisted public company (appointed March 2016), and Deputy Chairman of GWA Group Limited (appointed November 2010). He is also a current Non-Executive Director of various Zurich Australia Insurance subsidiaries.

Tonianne Dwyer

B Juris (Hons), LLB (Hons), GAICD

Independent Non-Executive Director

Tonianne Dwyer was appointed a Non-Executive Director of the Company on 1 July 2016. She has significant experience as a company director and executive working in finance, corporate strategy and mergers and acquisitions across a variety of sectors and international markets.

Siddhartha Kadia

Ph.D. Biomedical Engineering, B.E., Electronics and Telecommunication

Independent Non-Executive Director

Siddhartha Kadia was appointed a Non-Executive Director of the Company in January 2019. Siddhartha was formerly President and CEO of EAG Laboratories, a global scientific testing company headquartered in San Diego. He has a PhD in Biomedical Engineering from Johns Hopkins School of Medicine. Siddhartha has lived and worked in the US, Japan, China and India and has more than 20 years of international experience as a company director, executive and technical leader in the Life Sciences and TIC (testing, inspection and certification) sectors.

Leslie Desjardins

B. Industrial Admin, Finance (Kettering), MS. Management (MIT)

Independent Non-Executive Director

Leslie Desjardins was appointed a Non-Executive Director of the Company on 21 November 2019. She has a background as a CFO and senior financial and governance professional in a range of large multinational and global businesses. Ms Desjardins is currently a Director, Audit Committee Chair, CSR/Risk Committee member with Ansell Limited and Director and Audit Committee Chair with Terry Fox Foundation, Canada.

Peter Possemiers

B ASc., Chemistry/Microbiology, University of South Australia

Independent Non-Executive Director

Peter Possemiers has been named independent Non-Executive Director, effective November 1st, 2022. A 40-year veteran of the TIC sector, he held multiple executive leadership roles for SGS, most notably in global Environment Health and Safety, a CHF $550 million business. As Executive Vice President there, he was a member of their Operations Council with responsibility for growth and profitability, steering 15 strategic acquisitions. Mr. Possemiers is a respected leader with a deep understanding of TIC practices across multiple regions. His M&A track record and network relationships will provide invaluable insight and benefits for ALS Limited.

Erica Mann

Dip. Analytical Chemistry, Marketing Management, Small Business Development

Independent Non-Executive Director

Erica Mann was appointed a Non-Executive Director of the Company on 1 March 2024. She has experience across complex, highly regulated, multi-channel and multi-product environment in top DAX, NYSE, NSDAQ pharmaceutical, OTC and FMCG multinationals. Erica has deep experience with global and emerging markets across Africa, China, Russia and Brazil. She currently holds Non-Executive Director positions on the boards of Kellanova, DSM-Firmenich, and Perrigo.

 

ALS pillars

This is an image of people walking

Employees first

Being a global leader means assembling the right teams. We pride ourselves in recruiting top talent and offering a safe, inclusive, educational environment with the necessary resources to inspire continued growth.

  • Ensure a healthy work environment
    • Mandate critical safety guidelines
    • Provide health and wellness programs
    • Ensure supportive resources
  • Attract and develop a diverse workforce
    • Explore unconscious bias recruitment training
    • Build on reward/recognition programs
    • Invest in employee training and professional enrichment opportunities
    • Further develop inclusion initiatives

Taking steps to reduce our footprint

Environmental responsibility is a priority. Throughout our field work, we regularly seek opportunities to minimize our impact by conserving resources, reducing waste and more using more sustainable material.

  • Helping to minimize our carbon footprint
    • Tracking of carbon reduction plans for each business
    • Procurement of renewable energy

Global services. Local partners.

ALS offers testing and inspection services that help people all over the world. Through these efforts, we contribute to communities by creating shared value with our local partners. This includes providing employment opportunities and partnering with local contractors and suppliers.

  • Generating opportunities while giving back
    • Create jobs
    • Promote science education programs for students in local schools and universities
  • Stimulate local economies
    • Provide tax revenues across various countries in which we operate
    • Deliver high returns and create long-term value for shareholders
  • Uphold human rights
    • Recognize worker's rights across our global network
    • Maintain a safe and supportive work environment
    • Assessing working practices to ensure that human rights are respected

Operating ethically and responsibly

We hold ourselves to high standards of professional integrity. Regulatory frameworks promoting transparency and accountability allow us to build a trusting relationship with our stakeholders.

  • Maintain a fair workplace
    • Promote both an honest and ethical environment
  • Execute Enterprise Risk Management
    • Deliver sustainable outcomes for stakeholders
Key Contact image or woman and man talking

Key contacts

For more information please contact:

Investor enquiries

investor@alsglobal.com

BoardRoom Pty Ltd

Share Registry
PO Box 3993
Sydney, NSW
2001 Australia

T: 1300 737 760
F: +61 (0)2 9279 0664

enquiries@boardroomlimited.com.au

www.boardroomlimited.com.au

ALS Limited

PO Box 566
Fortitude Valley, Queensland
Australia 4006

T: +61 (0)7 3367 7900
F: +61 (0)7 3367 8156

 

 

GENERAL INFORMATION